| Name | Title | Contact Details |
|---|
Oxysure Systems is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
PureFlora was founded in 2012 by Tivon Sidorsky, MD after a family member’s severe case of C. difficile introduced him to the efficacy of fecal matter transplants (FMT) and the need for a standardized, sanitary, and labor reducing system by which to collect, process, and deliver fecal matter. Recognizing the tremendous opportunity for research and clinical applications for human gut microbiota and the elegant solution proposed by Dr. Sidorsky, veteran medical device executive William L. Mince joined forces with the inventor building the now-patented technology and team that is PureFlora.
The DePuy Synthes Companies offer the world’s most comprehensive portfolio of orthopaedic and neuro products and services for joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. Each of the companies that comprise DePuy Synthes Companies has a celebrated history, and each has evolved to meet the needs of the changing orthopaedics and neuro marketplace. The history that weaves the fabric of the DePuy Synthes Companies is one that is rich with innovation and demonstrates sustained leadership in an ever-changing landscape of patient and professional needs. The content from the DePuy Synthes Companies LinkedIn page is informational only. This content is not a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician with questions regarding a medical condition. Reliance on information provided herein is at your own risk. Comments which are off-topic, offensive, or promotional, are prohibited. Neither DePuy Synthes Companies nor any of its operating companies are responsible for third-party materials appearing on the DePuy Synthes Companies page, including but not limited to linked third-party videos, linked third-party sites, and third-party advertisements. DePuy Synthes Companies does not control or endorse this third-party content and makes no representations regarding its accuracy.
first health care group inc is a Bloomington, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
John R. Dwyer, Jr., JD, serves as the Chief Financial Officer and General Counsel of Telcare, Inc. Mr. Dwyer served as Principal of CodeRyte, Inc. He served as an Executive Vice President of Doctors Health, Inc. and also served as its Chief Financial Officer for 2 years. He served as a Principal of Graham, Hamilton & Dwyer, Inc. (“GHD“). He served as Chief Executive Officer of e-MEDx. He served as Chief Operating Officer of Active Health Management. He served as Chief Executive Officer of Vetcentric, a specialty on-line pharmacy. Mr. Dwyer served at Diametrics, Inc., where he served as President of California-based high technology Company. Mr. Dwyer began his professional career as an Attorney with Arent, Fox, Kintner, Plotkin & Kahn, the fifth largest law firm in Washington, D.C., where he focused on transactions in the health care and telecommunications industries. He serves as the Chairman of Redbricks.com, LLC. He serves on the Boards of a number of private and not-for-profit organizations including Earth Conservation Corp. He serves as a Director of the Trust for America's Health. He serves on the Executive Council of Leaders Engaged against Alzheimer's Disease (LEAD). He serves as a Director of USAgainstAlzheimer's. He served as the Chairman of Telcare, Inc. and serves as its Director. He served as a Director of CodeRyte, Inc. Mr. Dwyer served as a Member of the Obama Administration's HHS transition team and has played an active role in the HHS, FDA, and Commerce transition and staffing plans of the Administration. He co-founded the first political action committee focused on a particular disease, the Alzheimer's Action PAC. Mr. Dwyer is a frequent Speaker on financing and regulatory issues of critical importance to emerging health technology companies. He has spoken on health information issues, business risks associated with the FDA approval process, and patent insurance at a variety of forums including the BIO/CEO and AdvaMed annual conferences. Mr. Dwyer is a graduate of Marquette University and the Cornell University Law School.